SC 14C PREM14C EX-FILING FEES 0001549084 EKSO BIONICS HOLDINGS, INC. N/A 0-11 0001549084 2026-03-19 2026-03-19 0001549084 1 2026-03-19 2026-03-19 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

Table 1: Transaction Valuation

Proposed Maximum Aggregate Value of Transaction

Fee Rate

Amount of Filing Fee

Fees to be Paid 1 $ 1,457,496,367.00 0.0001381 $ 201,280.25
Fees Previously Paid

Total Transaction Valuation:

$ 1,457,496,367.00

Total Fees Due for Filing:

$ 201,280.25

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 201,280.25

Offering Note

1

(1) Calculated solely for the purpose of determining the filing fee in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The proposed maximum aggregate value of the transaction is calculated based on 138,216,820 shares of common stock, par value $0.001 per share (the "Common Stock"), of Ekso Bionics Holdings, Inc. ("Ekso") that will be issued to APLD ChronoScale Holdco LLC ("Contributor") in connection with the completion of the transactions contemplated by that certain Contribution and Exchange Agreement, dated as of February 15, 2026, by and among Ekso, Contributor, APLD Intermediate Holdco LLC and Applied Digital Cloud Corporation ("Cloud"), multiplied by $10.545, which is the average of the high and low price per share of Ekso Common Stock, as reported on the Nasdaq Capital Market on March 19, 2026. In accordance with Section 14(g) of the Exchange Act and Rule 0-11 of the Exchange Act, the filing fee was determined by multiplying the proposed maximum aggregate value of the transaction calculated in note (1) above by 0.00013810.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Fee Paid with Fee Offset Source
Fee Offset Claims
Fee Offset Sources